CEL Celadon Pharmaceuticals Plc

61.00

1.50 (2.52%)

22 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Celadon Pharmaceuticals Plc	LSE:CEL	London	Ordinary Share	GB00BDQYGP38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.50	2.52%	61.00	57.00	65.00	61.00	59.50	59.50	12,246	14:00:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Investment Advice	149k	-7.14M	-0.1082	-5.64	39.26M

Acqn Discussions Terminated

19/04/2001 8:00am

UK Regulatory

RNS Number:2788C
Celsis International PLC
19 April 2001


Celsis International plc

Celsis International plc announces that discussions with Biotec Laboratories
have been mutually terminated.  The Directors believe that to continue with
the planned acquisition, as outlined at the Interim Results in December 2000,
would not enhance shareholder value at this time given current market
conditions.

This decision does not alter the company's strategy of focusing on driving
profits through a combination of organic growth and selected acquisitions, as
summarised at the Interim Results.  In particular Celsis is now integrating
ConCell, a business acquired last month to reinforce the company's leading
position in the European dairy screening market.

Enquiries:

Celsis International plc Peter Grant/Jenny Parsons          01223 426 008

Brunswick Group Limited  Melissa Miller/Christina Freyberg  020 7404 5959